Skip to main content

Table 2 Cox proportional hazards regression model analysis of overall survival

From: Study on the expression of TOP2A in hepatocellular carcinoma and its relationship with patient prognosis

Variables

Univariate analysis

Multivariate analysis

HR (95% CI)

p

HR (95% CI)

p

Age (≥ 65 vs. < 65)

1.23 (0.85,1.78)

0.273

–

–

Gender (Female vs. Male)

1.26 (0.87,1.84)

0.228

–

–

Family history of cancer (YES vs. NO)

1.14 (0.76,1.69)

0.530

–

–

TNM stage (II vs. I)

1.42 (0.87,2.32)

0.160

1.14 (0.6,2.15)

0.694

TNM stage (III vs. I)

2.72 (1.78,4.15)

 < 0.001

2.03 (1.19,3.47)

0.010

TNM stage (IV vs. I)

5.44 (1.68,17.63)

0.005

6.91 (2.09,22.89)

0.002

Histologic grade (G3–G4 vs. G1–G2)

1.14 (0.78,1.67)

0.489

–

–

Ishak score (5–6 vs. 0–4)

0.87 (0.5,1.5)

0.612

–

–

Child–Pugh grade (B–C vs. A)

1.66 (0.82,3.36)

0.159

–

–

Vascular invasion (Micro vs. none)

1.16 (0.72,1.88)

0.539

1.07 (0.61,1.87)

0.824

Vascular invasion (Macro vs. none)

2.52 (1.14,5.58)

0.023

1.84 (0.8,4.24)

0.150

Alpha fetoprotein (positive vs. negative)

1.45 (0.92,2.28)

0.108

–

–

Residual tumor (R1–R2 vs. R0)

1.17 (0.43,3.2)

0.754

–

–

TOP2A (high vs. low)

1.26 (1.11,1.42)

 < 0.001

1.21 (1.04,1.39)

0.011

  1. Statistically signifcant p values are given in bold p < 0.05
  2. HR hazard ratio; CI confdence interval